Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Vor Biopharma Inc’s stock clocked out at $2.0, down -1.96% from its previous closing price of $2.04. In other words, the price has decreased by -$1.96 from its previous closing price. On the day, 3.96 million shares were traded. VOR stock price reached its highest trading level at $2.11 during the session, while it also had its lowest trading level at $1.99.
Ratios:
To gain a deeper understanding of VOR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.49 and its Current Ratio is at 3.49.
On July 26, 2022, Wedbush started tracking the stock assigning a Outperform rating and target price of $18.
On April 27, 2022, Goldman started tracking the stock assigning a Neutral rating and target price of $6.Goldman initiated its Neutral rating on April 27, 2022, with a $6 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 03 ’25 when Reprogrammed Interchange LLC bought 23,000,000 shares for $2.00 per share.
Reprogrammed Interchange LLC sold 806,351 shares of VOR for $1,621,975 on Aug 28 ’25. The 10% Owner now owns 36,884,567 shares after completing the transaction at $2.01 per share. On Aug 27 ’25, another insider, Reprogrammed Interchange LLC, who serves as the 10% Owner of the company, sold 611,647 shares for $2.01 each. As a result, the insider received 1,226,536 and left with 37,690,918 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VOR now has a Market Capitalization of 253366000 and an Enterprise Value of 52801224.
Stock Price History:
The Beta on a monthly basis for VOR is 2.05, which has changed by 1.4242425 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, VOR has reached a high of $3.29, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 0.19%, while the 200-Day Moving Average is calculated to be 77.94%.
Shares Statistics:
It appears that VOR traded 18.12M shares on average per day over the past three months and 4251310 shares per day over the past ten days. A total of 125.65M shares are outstanding, with a floating share count of 68.23M. Insiders hold about 46.14% of the company’s shares, while institutions hold 39.15% stake in the company. Shares short for VOR as of 1755216000 were 18414934 with a Short Ratio of 1.02, compared to 1752537600 on 14383629. Therefore, it implies a Short% of Shares Outstanding of 18414934 and a Short% of Float of 38.419998.
Earnings Estimates
The market rating for Vor Biopharma Inc (VOR) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$13.23 and -$13.23 for the fiscal current year, implying an average EPS of -$13.23. EPS for the following year is -$0.4, with 4.0 analysts recommending between -$0.07 and -$0.78.
